➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Dow
McKesson
Baxter

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

HALOPERIDOL DECANOATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for haloperidol decanoate and what is the scope of patent protection?

Haloperidol decanoate is the generic ingredient in two branded drugs marketed by Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, and Zydus Pharms, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol decanoate. Eleven suppliers are listed for this compound.

Drug Prices for HALOPERIDOL DECANOATE

See drug prices for HALOPERIDOL DECANOATE

Drug Sales Revenue Trends for HALOPERIDOL DECANOATE

See drug sales revenues for HALOPERIDOL DECANOATE

Recent Clinical Trials for HALOPERIDOL DECANOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institutes of Health (NIH)Phase 3
Case Western Reserve UniversityPhase 3
New York State Psychiatric InstitutePhase 4

See all HALOPERIDOL DECANOATE clinical trials

Pharmacology for HALOPERIDOL DECANOATE

US Patents and Regulatory Information for HALOPERIDOL DECANOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075393-002 May 11, 1999 AO RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 211180-002 Oct 22, 2019 AO RX No No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-001 May 12, 2017 AO RX No No   Start Trial   Start Trial   Start Trial
Hospira HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075176-002 Feb 9, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Baxter
McKesson
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.